JP2008504335A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008504335A5 JP2008504335A5 JP2007518555A JP2007518555A JP2008504335A5 JP 2008504335 A5 JP2008504335 A5 JP 2008504335A5 JP 2007518555 A JP2007518555 A JP 2007518555A JP 2007518555 A JP2007518555 A JP 2007518555A JP 2008504335 A5 JP2008504335 A5 JP 2008504335A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- double
- building blocks
- molecule
- nucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58467804P | 2004-07-02 | 2004-07-02 | |
| US64658605P | 2005-01-26 | 2005-01-26 | |
| PCT/EP2005/007198 WO2006002971A2 (en) | 2004-07-02 | 2005-07-04 | Nucleic acids for the treatment of hmgb1-related pathologies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008504335A JP2008504335A (ja) | 2008-02-14 |
| JP2008504335A5 true JP2008504335A5 (cg-RX-API-DMAC7.html) | 2008-08-21 |
Family
ID=35106975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007518555A Pending JP2008504335A (ja) | 2004-07-02 | 2005-07-04 | Ｈｍｇｂ１に関連する病変の治療のための核酸 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080305073A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1768677B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008504335A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE399014T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005259381A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0512944A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2572519A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE602005007746D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1768677T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2306195T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL179828A0 (cg-RX-API-DMAC7.html) |
| PL (1) | PL1768677T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1768677E (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006002971A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006017647A1 (en) | 2004-08-03 | 2006-02-16 | Transtech Pharma, Inc. | Rage fusion proteins and methods of use |
| US20100172909A1 (en) * | 2005-10-24 | 2010-07-08 | Masahiro Nishibori | Cerebral edema suppressant |
| EA015657B1 (ru) * | 2006-02-09 | 2011-10-31 | Транстек Фарма, Инк. | Слитые белки rage и способы применения |
| JP3882090B1 (ja) * | 2006-05-19 | 2007-02-14 | 国立大学法人 岡山大学 | 脳血管攣縮抑制剤 |
| US20100056608A1 (en) * | 2006-11-17 | 2010-03-04 | Clinical Gene Networks Ab | Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb 3, hsdl2 and/or ldb2 |
| CN101589309A (zh) * | 2006-11-17 | 2009-11-25 | 临床基因网络公司 | 涉及基因gypc、agpat3、agl、pvrl2、hmgb3、hsdl2和/或ldb2的筛选和治疗方法 |
| US8927510B2 (en) | 2008-05-16 | 2015-01-06 | Children's Medical Center Corporation | Compositions and methods for inhibition of retroviruses |
| AU2009256906A1 (en) * | 2008-06-11 | 2009-12-17 | Bionucleon S.R.L. | Inhibition of HRP-3 using modified oligonucleotides |
| CN102209897B (zh) | 2008-09-11 | 2015-04-29 | 巴斯德研究院 | 通过调节hiv-1复制和顽固存在的hmgb1依赖性触发来监测和抑制人免疫缺陷病毒感染 |
| US20120165244A1 (en) * | 2008-10-30 | 2012-06-28 | Hua-Lin Wu | Methods for binding lewis y antigen |
| MX2011006456A (es) | 2008-12-22 | 2011-10-11 | Creabilis S A | Sintesis de conjugados de polimero de compuestos de indolocarbazola. |
| RU2011142230A (ru) | 2009-04-20 | 2013-05-27 | Пфайзер Инк. | Контроль гликозилирования белка и композиции и способы, касающиеся этого |
| GB0911569D0 (en) * | 2009-07-03 | 2009-08-12 | Ulive Entpr Ltd | Method for the detection of organ or tissue injury |
| JP5467313B2 (ja) * | 2009-09-28 | 2014-04-09 | 国立大学法人 岡山大学 | アテローム動脈硬化抑制剤 |
| US8975019B2 (en) * | 2009-10-19 | 2015-03-10 | University Of Massachusetts | Deducing exon connectivity by RNA-templated DNA ligation/sequencing |
| EP2617426B1 (en) * | 2010-09-17 | 2016-08-10 | Japan Science and Technology Agency | Inhibitor of hmgb protein-mediated immune response activation |
| US20140378531A1 (en) * | 2012-02-01 | 2014-12-25 | New York University | Inhibition of pattern recognition receptors in pancreatic cancer treatment using tlr inhibitors |
| JP6624542B2 (ja) * | 2015-02-05 | 2019-12-25 | 国立大学法人広島大学 | ヒトｈｍｇｂ１結合剤およびヒトｈｍｇｂ１除去装置 |
| WO2018175301A1 (en) | 2017-03-20 | 2018-09-27 | Sienna Biopharmaceuticals, Inc. | Polymer conjugate of montesanib with reduced exposure |
| WO2018175340A1 (en) | 2017-03-20 | 2018-09-27 | Sienna Biopharmaceuticals, Inc. | Reduced exposure conjugates modulating therapeutic targets |
| WO2018175315A1 (en) | 2017-03-20 | 2018-09-27 | Sienna Biopharmaceuticals, Inc. | Polymer conjugates of staurosporine derivatives having reduced exposure |
| WO2018175302A1 (en) | 2017-03-20 | 2018-09-27 | Sienna Biopharmaceuticals, Inc. | Polymer conjugates targeting c-src with reduced exposure |
| EP3621657A1 (en) | 2017-05-10 | 2020-03-18 | Sienna Biopharmaceuticals, Inc. | Uses of polymer conjugates of indolocarbazole compounds with reduced exposure |
| CN111304202B (zh) * | 2020-02-26 | 2023-03-28 | 西安交通大学 | 一种用于识别且增强hmgb1生物学活性的核酸适配子及其应用 |
| CN114957440A (zh) * | 2022-05-26 | 2022-08-30 | 江苏大学 | 一种重组HMGB1 A Box蛋白及其获取方法与应用 |
| JP2025521607A (ja) * | 2022-06-23 | 2025-07-10 | ザ ジェイ． デビッド グラッドストーン インスティテューツ、 ア テスタメンタリー トラスト エスタブリッシュド アンダー ザ ウィル オブ ジェイ． デビッド グラッドストーン | アルツハイマー病を含むａｐｏｅ４－関連タウオパチーの治療のためのｈｍｇｂ１阻害剤 |
| CN114807150B (zh) * | 2022-06-28 | 2022-10-14 | 中国科学院基础医学与肿瘤研究所(筹) | 靶向和拮抗hmgb1分子的核酸适体 |
| AU2023308977A1 (en) | 2022-07-19 | 2025-03-06 | Rampart Bioscience, Inc. | Non-immunogenic circular, non-viral dna vectors |
| CN115774004B (zh) * | 2022-08-19 | 2024-07-05 | 四川大学华西医院 | 二氧化锆@量子点复合微球在制备检测hmgb1的荧光探针中的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0672188B1 (en) * | 1992-10-14 | 2003-12-10 | NeXstar Pharmaceuticals, Inc. | Method for selecting nucleic acids on the basis of structure |
| ITMI20010562A1 (it) * | 2001-03-16 | 2002-09-16 | Marco E Bianchi | Inibitori o antagonisti della proteina hmg1 per il trattamento di disordini vascolari |
| WO2004046345A2 (en) * | 2002-11-20 | 2004-06-03 | Critical Therapeutics, Inc. | Use of hmgb fragments as anti-inflammatory agents |
-
2005
- 2005-07-04 WO PCT/EP2005/007198 patent/WO2006002971A2/en not_active Ceased
- 2005-07-04 BR BRPI0512944-3A patent/BRPI0512944A/pt not_active IP Right Cessation
- 2005-07-04 DE DE602005007746T patent/DE602005007746D1/de not_active Revoked
- 2005-07-04 DK DK05773148T patent/DK1768677T3/da active
- 2005-07-04 ES ES05773148T patent/ES2306195T3/es not_active Expired - Lifetime
- 2005-07-04 CA CA002572519A patent/CA2572519A1/en not_active Abandoned
- 2005-07-04 US US11/631,328 patent/US20080305073A1/en not_active Abandoned
- 2005-07-04 PL PL05773148T patent/PL1768677T3/pl unknown
- 2005-07-04 PT PT05773148T patent/PT1768677E/pt unknown
- 2005-07-04 AT AT05773148T patent/ATE399014T1/de not_active IP Right Cessation
- 2005-07-04 JP JP2007518555A patent/JP2008504335A/ja active Pending
- 2005-07-04 AU AU2005259381A patent/AU2005259381A1/en not_active Abandoned
- 2005-07-04 EP EP05773148A patent/EP1768677B1/en not_active Revoked
-
2006
- 2006-12-04 IL IL179828A patent/IL179828A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008504335A5 (cg-RX-API-DMAC7.html) | ||
| JP7672163B2 (ja) | 核酸、当該核酸を含む組成物及び複合体ならびに調製方法と使用 | |
| JP5798549B2 (ja) | ヘプシジン結合核酸 | |
| CN104053777B (zh) | 与靶蛋白质结合的核酸片段 | |
| US8835471B2 (en) | Use of angiotensin II agonists | |
| JP2010533171A5 (cg-RX-API-DMAC7.html) | ||
| US20120322862A1 (en) | Aptamers to 4-1BB and Their Use in Treating Diseases and Disorders | |
| JP2008511300A5 (cg-RX-API-DMAC7.html) | ||
| US20220235359A1 (en) | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use | |
| JP2008518608A5 (cg-RX-API-DMAC7.html) | ||
| JP2012050438A5 (cg-RX-API-DMAC7.html) | ||
| WO2006002971A2 (en) | Nucleic acids for the treatment of hmgb1-related pathologies | |
| CN105683377A (zh) | 呼吸疾病相关基因特异性siRNA、含有siRNA的双螺旋寡RNA结构、含有它们的组合物用于预防或治疗呼吸疾病 | |
| JP2015509705A5 (cg-RX-API-DMAC7.html) | ||
| TW202012624A (zh) | 用以調節atxn2 表達之寡核苷酸 | |
| RU2010116245A (ru) | НУКЛЕИНОВЫЕ КИСЛОТЫ, СВЯЗЫВАЮЩИЕ C5a | |
| JP2021513365A (ja) | スクレロスチンに対するアプタマー及びその使用 | |
| WO2023241591A1 (zh) | 调控PCSK9基因活性的siRNA分子 | |
| CN102973554B (zh) | 土木香内酯在制备防治溃疡性结肠炎的药物或食品中的应用 | |
| CN101148666A (zh) | 一组与人乳腺癌组织高特异性和高亲和力的核酸适配子及其制备方法与应用 | |
| CN121001748A (zh) | 可编程dna蛋白水解靶嵌合体及其使用方法 | |
| TWI335219B (en) | Virus therapeutic drug | |
| JP2011505798A5 (cg-RX-API-DMAC7.html) | ||
| JP6049143B2 (ja) | オリゴヌクレオチド、グルココルチコイド感受性増強剤、医薬組成物、及び発現ベクター | |
| JP6993230B2 (ja) | キメラデコイ |